MedTrace Logo

The Effect of Free Weight Resistance Training and Body Composition on Cognition

NCT06662487 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-10-30

No results posted yet for this study

Summary

This study, titled The Effect of Free Weight Resistance Training (FWRT) on Cognitive Function Explored through Eye Tracking, will be a randomized double-blind clinical trial aimed at evaluating how FWRT influences cognitive processing in healthy young adults. Eye-tracking technology will be used to measure reading metrics and DXA scans will be used to measure body composition before and after a 10-week FWRT intervention.

Participants will be randomly assigned to either an experimental group, which will undergo a 10-week FWRT program, or a control group. This study will provide insights into the potential benefits of free weight resistance training on the cognitive performance of text processing tasks.

Conditions

  • Cognitive Performance

Interventions

BEHAVIORAL

Resistance Training

Participants in the experimental group will perform free weight resistance training sessions focused on push, pull, and leg movement patterns. The program will last for 10 weeks, progressively increasing in load and intensity. The intervention will be designed to improve the participants' physical strength and observe how these changes affect their cognitive performance.

Sponsors & Collaborators

  • Pontificia Universidad Catolica de Valparaiso

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2024-08-30
Completion
2024-10-20

Countries

  • Chile

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06662487 on ClinicalTrials.gov